[go: up one dir, main page]

IN2013MU03311A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03311A
IN2013MU03311A IN3311MU2013A IN2013MU03311A IN 2013MU03311 A IN2013MU03311 A IN 2013MU03311A IN 3311MU2013 A IN3311MU2013 A IN 3311MU2013A IN 2013MU03311 A IN2013MU03311 A IN 2013MU03311A
Authority
IN
India
Prior art keywords
burns
leaving
treatment
active ingredients
scar mark
Prior art date
Application number
Inventor
Dr Surendra Kumar Gupta
Ankita Gupta
Sakshi Gupta
Original Assignee
Dr Surendra Kumar Gupta
Ankita Gupta
Sakshi Gupta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Surendra Kumar Gupta, Ankita Gupta, Sakshi Gupta filed Critical Dr Surendra Kumar Gupta
Priority to IN3311MU2013 priority Critical patent/IN2013MU03311A/en
Publication of IN2013MU03311A publication Critical patent/IN2013MU03311A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

This invention is based on ayurvedic formulation which comprises two or more active ingredients for treatment of burns without leaving any scar mark.
IN3311MU2013 2013-10-22 2013-10-22 IN2013MU03311A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3311MU2013 IN2013MU03311A (en) 2013-10-22 2013-10-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3311MU2013 IN2013MU03311A (en) 2013-10-22 2013-10-22

Publications (1)

Publication Number Publication Date
IN2013MU03311A true IN2013MU03311A (en) 2015-07-17

Family

ID=54397351

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3311MU2013 IN2013MU03311A (en) 2013-10-22 2013-10-22

Country Status (1)

Country Link
IN (1) IN2013MU03311A (en)

Similar Documents

Publication Publication Date Title
ZA202004557B (en) Modulatory polynucleotides
PH12019550050A1 (en) Isoxazole analogs as fxr agonists and methods of use thereof
PH12017500941A1 (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
MX380250B (en) CHK-1 KINASE INHIBITOR PHARMACEUTICAL COMPOUNDS.
PH12019502646A1 (en) Pyrazole magl inhibitors
MY192717A (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
EA201491505A1 (en) CONNECTIONS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY
EA201891199A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
MD3204025T2 (en) Compositions containing bacterial strains
EA201890047A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201890048A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
SG10201806849WA (en) Cyclopropylamines as lsd1 inhibitors
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
PH12015502161A1 (en) Therapeutic compounds and compositions
MX386935B (en) PRODRUGS OF FUMARATES AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES.
EP4450130A3 (en) Formulations of enzalutamide
PH12016501441A1 (en) Chimeric alkaline phosphate-like proteins
MX2017004808A (en) Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX379271B (en) Compounds for treatment of cancer
CR20150417A (en) AZETIDINYLOXYPHENYLPIRROLIDINE COMPOUNDS
MX2016008150A (en) Berberine formulations and uses thereof.
GEP20186920B (en) Halogenated quinazolinthf-amines as pde1 inhibitors
MX2016004078A (en) Hiv treatment formulation of atazanavir and cobicistat.
MX373197B (en) STABLE FORMULATIONS OF TESTOSTERONE UNDECANOATE.